Safe anesthesia practice in patients with lipin-1 deficiency: a case report and narrative review
Abstract
Lipin-1 deficiency is a rare recessive autosomal disorder which causes recurrent episodes of rhabdomyolysis. These episodes are frequently initiated by a triggering event such as febrile illness, exercise or fasting. Anesthesia has also been claimed to provoke rhabdomyolysis in these patients. These episodes start in early childhood and often require intensive treatment which is complicated by a high morbidity and mortality. We present a review of the available literature and analyzed the data of 80 lipin-1 deficient patients. We found 79 cases published in 24 articles. We also report our own patient. Analysis of this data could not provide documentation proving a causal relationship between anesthesia and a rhabdomyolysis episode. We found four case reports of anesthetic procedures in lipin-1 deficient patients. These patients had been given an intravenous glucose infusion to avoid the induction of a catabolic state. The procedures were uncomplicated and did not provoke rhabdomyolysis. We present the case of a 14 year old boy requiring several surgical and anesthetic procedures. Administration of intravenous glucose was part of our strategy to prevent the perioperative occurrence of rhabdomyolysis. We provide detailed information about the agents we used for the anesthetic management of this patient. We hypothesize that not the anesthetic exposure but other factors might cause rhabdomyolysis in the perioperative period. These factors include fasting, inflammation, the…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.